Previous Section
Review Articles
38. Evaluation of the L-stereoisomeric nucleoside analog troxacitabine for the treatment of acute myeloid leukemia.
- Author
- Quintas-Cardama A; Cortes J;
- Institution
- University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX 77030, USA.
- Journal
- Expert Opin Investig Drugs. 2007 Apr;16(4):547-57.
- Abstract URL
- Click here to view abstract
39. An analysis of current neutropenia therapies, including pegfilgrastim.
- Author
- Gabrilove JL;
- Institution
- Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA. janice.gabrilove@mssm.edu
- Journal
- Clin Cornerstone. 2006;8 Suppl 5:S19-28.
- Abstract URL
- Click here to view abstract
40. Dendritic cell vaccines for leukemia patients.
- Author
- Schmitt A; Hus I; Schmitt M; Schmitt A; Hus I; Schmitt M;
- Institution
- Tumor Immunology Group, University of Ulm, Clinic for Internal Medicine III, Robert-Koch-Str. 8, 89081 Ulm, Germany. anita.schmitt@uni-ulm.de
- Journal
- Expert Rev Anticancer Ther. 2007 Mar;7(3):275-83.
- Abstract URL
- Click here to view abstract
41. The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes.
- Author
- Bhatia M; Davenport V; Cairo MS;
- Institution
- Departments of Pediatrics, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University, New York, NY 10032, USA.
- Journal
- Leuk Lymphoma. 2007 Jan;48(1):9-15.
- Abstract URL
- Click here to view abstract
